Hepatology Research Fellowship

EURAXESS Ireland; Strasbourg; Hybride; EUR 40 000 - 48 000; Plein temps

Résumé du poste

The Institute for Translational Medicine and Liver Disease (ITM), Inserm U1110, University of Strasbourg, France, is looking for a medical doctor to join our translational liver disease and cancer program as a physician-scientist in a three-year PhD-track. The program focuses on hepatobiliary fibrosis and liver cancer using translational approaches.

The successful candidate will benefit from an international training environment, access to cutting-edge technologies, and the option to obtain a

Qualifications

• Medical doctor in training or with specialization in internal medicine, gastroenterology, surgery, or oncology.
• Strong interest in biomedical research and translational hepatology.
• Excellent English; French not required.

Responsabilités

• Conduct translational research in hepatology and liver cancer.
• Collaborate with pharma and leading institutions for translational projects.
• Pursue PhD within the MD-PhD program and contribute to the liver disease program.

Connaissances

English

Formation

Master's degree or equivalent

Description du poste

Institute for Translational Medicine and Liver Disease

Organisation/Company Institute for Translational Medicine and Liver Disease Department UMR_S1110 Research Field Medical sciences » Medicine Biological sciences » Biology Researcher Profile First Stage Researcher (R1) Positions PhD Positions Application Deadline 30 Nov 2026 - 17:00 (Europe/Paris) Country France Type of Contract Temporary Job Status Full-time Offer Starting Date 1 Jan 2027 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No

Offer Description

The Institute for Translational Medicine and Liver Disease (ITM),Inserm U1110, University of Strasbourg France, is looking for a medical doctor to join our translational liver disease and cancer program as a physician scientist in a three-year program. The program is focussed to unravel novel strategies to treat hepatobiliary fibrosis (such as MASH and PSC) and liver cancer including hepatocellular and cholangiocarcinoma and is based on key scientific discoveries described in: Mailly et al. Nature Biotech 2015, Hamdane et al. Gastroenterology 2019, Juehling et al. Gut 2021, Crouchet et al. Nat. Commun. 2021, Roehlen et al. Science Transl. Med 2022, Roehlen et al. J. Hepatol. 2023, Del Zompo et al. J Hepatol 2025, Saviano et al. Nature Reviews Cancer 2026, Slovic et al. Hepatology 2026, Crouchet et al., JCI 2025; Nehme et al. Science Transl. Med 2026.

What we offer

The institute is a world-class organisation of scientific excellence, training, and innovation in the heart of Europe within a high-quality environment of pharma, academia, and medical care. The successful candidate will benefit from:

• An international and vibrant state-of-the-art training environment in biomedical research


• Cutting-edge technologies including sc/snRNA and spatial transcriptomics, patient-derived models, systems biology and AI platforms


• Opportunity to obtain a PhD within the U Strasbourg MD-PhD program


• Tenure track program at Inserm and U Strasbourg towards assistant and associate professor level positions (both research and clinical positions), pharma network


• Close collaborations with pharma and world-class leading institutions in the field, including the Yale School of Medicine Liver Center, University of Tübingen, Massachusetts General Hospital, Harvard Medical School, UTSW Dallas and Sorbonne University Paris, AP-HP


• Opportunity for part-time concomitant hospital appointment or clinical work at the Gastroenterology-Hepatology Service of the Strasbourg University Hospitals if desired.

Profile

A medical doctor following completion of medical studies, in training or following specialization in internal medicine, gastroenterology, surgery, oncology (board certification not required) with a first experience and strong interest in biomedical research, and the ambition to contribute to an innovative program. Strong communicator with solid command of English (French is not required). Drive and motivation to execute a project in translational research. You thrive in a fast-paced and exciting scientific environment with the opportunity for contributing to a biomedical translational research program in Hepatology.

Deadline for applications: November 30, 2026 - possible start date from January 1, 2027.

Requirements

Research Field Medical sciences Education Level Master Degree or equivalent

Languages ENGLISH Level Excellent

Additional Information

Work Location(s)

Number of offers available 1 Company/Institute Institute for Translational Medicine and Liver Disease Country France City Strasbourg Postal Code 67000 Street 3 rue Koeberlé Geofield